Stereoselective synthesis of the C(1)-C(11) fragment of peloruside A

Organic Letters

Volumn 7, Issue 18, 2005, Pages 3941-3944

  Owen, Robert M ^a   Roush, William R ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Scripps Florida ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED HETEROCYCLIC RINGS; LACTONE; PELORUSIDE A;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

BICYCLO COMPOUNDS, HETEROCYCLIC; CATALYSIS; LACTONES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 24944453595     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0514303     Document Type: Article

References (45)

1. West, L. M.; Northcote, P. T. J. Org. Chem. 2000, 65, 445.
2. For recent reviews on microtubule-stabilizing agents, see: (a) Myles, D. C. Ann. Rep. Med. Chem. 2002, 37, 125.
3. (b) He, L.; Orr, G. A.; Horwitz, S. B. Drug Discov. Today 2001, 6, 1153.
4. (c) Altmann, K.-H. Curr. Opin. Chem. Biol. 2001, 5, 424.
5. Hood, K. A.; Bäckström, B. T.; West, L. M.; Northcote, P. T.; Berridge, M. V.; Miller, J. H. Anti-Cancer Drug Des. 2001, 16, 155.
6. Hood, K. A.; West, L. M.; Rouwé, B.; Northcote, P. T.; Berridge, M. V.; Wakefield, S. J.; Miller, J. H. Cancer Res. 2002, 62, 3356.
7. Gaitanos, T. N.; Buey, R. M.; Díaz, J. F.; Northcote, P. T.; Teesdale-Spittle, P.; Andreu, J. M.; Miller, J. H. Cancer Res. 2004, 64, 5063.
8. Miller, J. H.; Rouwé, B.; Gaitanos, T. N.; Hood, K. A.; Crume, K. P.; Bäckström, B. T.; La Flamme, A. C.; Berridge, M. V.; Northcote, P. T. Apoptosis 2004, 9, 785.
9. Liao, X.; Wu, Y.; De Brabander, J. K. Angew. Chem., Int. Ed 2003, 42, 1648.
10. Jin, M.; Taylor, R. E. Org. Lett. 2005, 7, 1303.
11. (a) Roulland, E.; Ermolenko, M. S. Org. Lett. 2005, 7, 2225.
12. (b) Cox, J. M.; Furuichi, N.; Zheng, C. S.; Smith, A. B. Abstracts of Papers, 228th National Meeting of the American Chemical Society, Philadelphia, August 22-26, 2004; American Chemical Society: Washington, DC, 2004; ORGN-378.
13. (c) Engers, D. W.; Bassindale, M. J.; Pagenkopf, B. L. Org. Lett. 2004, 6, 663.
14. (d) Liu, B.; Zhou, W.-S. Org. Lett. 2004, 6, 71.
15. (e) Gurjar, M. K.; Pedduri, Y.; Ramana, C. V.; Puranik, V. G.; Gonnade, R. G. Tetrahedron Lett. 2004, 45, 387.
16. (f) Stocker, B. L.; Teesdale-Spittle, P.; Hoberg, J. O. Eur. J. Org. Chem. 2004, 2, 330.
17. (g) Heady, T. N.; Crimmins, M. T. Abstracts of Papers, 225th National Meeting of the American Chemical Society, New Orleans, March 23-27, 2003; American Chemical Society: Washington, DC, 2004; ORGN-408.
18. (h) Taylor, R. E.; Jin, M. Org. Lett. 2003, 5, 4959.
19. (i) Ghosh, A. K.; Kim, J.-H. Tetrahedron Lett. 2003, 44, 7659.
20. (j) Paterson, I.; Di Francesco, M. E.; Kühn, T. Org. Lett. 2003, 5, 599.
21. (k) Ghosh, A. K.; Kim, J.-H. Tetrahedron Lett. 2003, 44, 3967.
22. (l) Vergin, A. J. B.; Ryba, T. D. Abstracts of Papers, 225th National Meeting of the American Chemical Society, New Orleans, March 23-27, 2003; American Chemical Society: Washington, DC, 2004; CHED-494.
23. (m) Smalley, M. K.; Hoye, T. R.; Tennakoon, M. Abstracts of Papers, 221th National Meeting of the American Chemical Society, San Diego, April 1-5, 2001; American Chemical Society: Washington, DC, 2001; CHED-234.
24. Flamme, E. M.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 13644.
25. (a) Asari, T.; Ishikawa, S.; Sasaki, T.; Katada, J.; Hayashi, Y.; Harada, T.; Yano, M.; Yasuda, E.; Uno, I.; Ojima, I. Bioorg. Med. Chem. Lett. 1997, 7, 2099.
26. (b) Chiba, T.; Sakaki, J.; Takahashi, T.; Aoki, K.; Kamiyama, A.; Kaneko, C.; Sato, M. J. Chem. Soc., Perkin Trans. 1 1987, 1, 1845.
27. Overman, L. E.; Bell, K. L.; Ito, F. J. Am. Chem. Soc. 1984, 106, 4192.
28. Brown, H. C.; Singaram, B. J. Org. Chem. 1984, 49, 945.
29. 1H NMR anlaysis of the bis-Mosher ester prepared from the 1,5-diol: Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092. See Supporting Information for details.
30. (a) Racherla, U. S.; Brown, H. C. J. Org. Chem. 1991, 56, 401.
31. (b) Brown, H. C.; Randad, R. S.; Bhat, K. S.; Zaidlewicz, M.; Racherla, U. S. J. Org. Chem. 1990, 55, 2389.
32. 1H NMR spectra of the bis-Mosher esters.
33. (a) Rossiter, B. E.; Verhoeven, T. R.; Sharpless, K. B. Tetrahedron Lett. 1979, 20, 4733.
34. (b) Hoffmann, R. W. Chem. Rev. 1989, 89, 1841.
35. (a) Nacro, K.; Gorrichon, L.; Escudier, J.-M.; Baltas, M. Eur. J. Org. Chem. 2001, 22, 4247.
36. (b) Devianne, G.; Escudier, J.-M.; Baltas, M.; Gorrichon, L. J. Org. Chem. 1995, 60, 7343.
37. Rychnovsky, S. D.; Rogers, B. N.; Richardson, T. I. Acc. Chem. Res. 1998, 31, 9. See Supporting Information for details.
38. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092. See Supporting Information for details.
39. See Supporting Information for details.
40. (a) Evans, D. A.; Connell, B. T. J. Am. Chem. Soc. 2003, 125, 10899.
41. (b) Ireland, R. E.; Smith, M. G. J. Am. Chem. Soc. 1988, 110, 854.
42. Evans, D. A.; Bender, S. L. Tetrahedron Lett. 1986, 27, 799.
43. Acyloxazolidinone 20 is avalible in two steps from known α-benzyloxy-protected glycolate oxazolidinone: Haigh, D.; Birrell, H. C.; Cantello, B. C. C.; Eggleston, D. S.; Haltiwanger, R. C.; Hindley, R. M.; Ramaswamy, A.; Stevens, N. C. Tetrahedron: Asymmetry 1999, 10, 1353. See Supporting Information for details.
44. We presume that the minor aldol product derives from the minor enantiomer of 18 since the % ee of the major diastereomer (determined for compound 21) was >95% by Mosher ester analysis. See Supporting Information for details.
45. The relative C(3)-C(5) stereochemistry of 19 was confirmed via the Rychnovsky method. See Supporting Information for details.